Foresite Capital Management IV’s Pharvaris PHVS Stock Holding History

Foresite Capital Management IV’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$135M	Hold	4,778,581	–	–	56.94%	1
2025 Q4	$133M	Hold	4,778,581	–	–	57.73%	1
2025 Q3	$119M	Buy	4,778,581 +368,000	+8%	+$8.16M	65.29%	1
2025 Q2	$77.6M	Hold	4,410,581	–	–	62.7%	1
2025 Q1	$69.2M	Buy	4,410,581 +12,700	+0.3%	+$214K	62.35%	1
2024 Q4	$84.3M	Hold	4,397,881	–	–	77.49%	1
2024 Q3	$81.4M	Buy	4,397,881 +104,027	+2%	+$1.9M	53.23%	1
2024 Q2	$80.7M	Buy	4,293,854 +255,012	+6%	+$5.19M	54.23%	1
2024 Q1	$93.3M	Hold	4,038,842	–	–	47.16%	1
2023 Q4	$113M	Buy	4,038,842 +295,392	+8%	+$5.98M	57.25%	1
2023 Q3	$78.1M	Hold	3,743,450	–	–	43.39%	1
2023 Q2	$56.7M	Buy	3,743,450 +496,524	+15%	+$4.8M	27.86%	1
2023 Q1	$26.2M	Hold	3,246,926	–	–	13.57%	2
2022 Q4	$36.5M	Hold	3,246,926	–	–	15.6%	3
2022 Q3	$24.9M	Hold	3,246,926	–	–	8.01%	5
2022 Q2	$71.8M	Sell	3,246,926 -15,000	-0.5%	-$280K	19.32%	3
2022 Q1	$59.2M	Hold	3,261,926	–	–	16.55%	3
2021 Q4	$46.9M	Hold	3,261,926	–	–	9.66%	4
2021 Q3	$57.8M	Hold	3,261,926	–	–	8.52%	4
2021 Q2	$60.8M	Hold	3,261,926	–	–	8.21%	3
2021 Q1	$91.3M	Buy	+3,261,926	New	+$103M	10.93%	2

Other funds holding PHVS

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $1.02B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Foresite Capital Management IV's PHVS Position: Q1 2026 in Review

Foresite Capital Management IV held its Pharvaris (PHVS) position steady in Q1 2026 at 4,778,581 shares worth $135M. The position accounts for 56.94% of the portfolio, ranked #1.

Foresite Capital Management IV first reported a position in PHVS in Q1 2021 and has held it in 21 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

Foresite Capital Management IV held 4,778,581 shares of Pharvaris worth $135M as of Q1 2026.
Foresite Capital Management IV left its Pharvaris share count unchanged in Q1 2026.
Pharvaris made up 56.94% of Foresite Capital Management IV's portfolio in Q1 2026, its #1 holding.
Foresite Capital Management IV first reported a position in Pharvaris in Q1 2021 and has held it in 21 quarters since.
110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Foresite Capital Management IV's 13F filing for Q1 2026, filed 15 May 2026.